Related Experiment Video
Updated: Dec 26, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
[Surface coatings to avoid dual antiplatelet therapy]
1Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes, 66421, Kirrberger Straße, Deutschland. ruben.muehl-benninghaus@uks.eu.
Abstract:
The development of microstents for aneurysm treatment has greatly expanded endovascular aneurysm therapy. Due to the increased amount of foreign material, the use of such stents is associated with an increased risk of thrombus formation and therewith the associated risk of ischemic stroke. For this reason, various surface coatings have recently been developed. The primary aim of these coatings is to reduce the foreign matter-mediated platelet adhesion to the stent surfaces. The potential reduction of dual antiplatelet therapy when using coated stents was recently discussed. But currently, no neurointerventional guidelines or recommendations endorse the stent implantation under single antiplatelet therapy. This article describes the different coatings in the field of neurointervention and their mode of action.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peripheral Artery Disease III: Interprofessional Care

